This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romanenkova, N. I.
Right arrow Articles by Delpeyroux, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romanenkova, N. I.
Right arrow Articles by Delpeyroux, F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2006, p. 4077-4084, Vol. 44, No. 11
0095-1137/06/$08.00+0     doi:10.1128/JCM.00017-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Use of a Multiple Restriction Fragment Length Polymorphism Method for Detecting Vaccine-Derived Polioviruses in Clinical Samples{triangledown}

Natalia I. Romanenkova,1* Sophie Guillot,2 Nadejda R. Rozaeva,1 Radu Crainic,2 Maina A. Bichurina,1 and Francis Delpeyroux2*

Subnational Poliomyelitis Laboratory, Saint-Petersburg Pasteur Institute, St. Petersburg, Russia,1 Unit of Molecular Prevention and Therapy of Human Diseases, CNRS FRE 2849, Pasteur Institute, Paris, France2

Received 4 January 2006/ Returned for modification 1 March 2006/ Accepted 29 August 2006

Since the announcement of the WHO program for the global eradication of poliomyelitis and the establishment of epidemiological and virological surveillance, the emergence and circulation of pathogenic vaccine-derived polioviruses (VDPV) presenting >1% nucleotide divergence from the sequence of the original vaccine strain have been demonstrated in certain regions. We developed and used a multiple restriction fragment length polymorphism (RFLP) method to investigate the frequency of these VDPV in a population with a high level of oral poliovirus vaccine coverage in northwestern Russia. Modified RFLP profiles were found to be strongly correlated with the presence of mutations and recombination events in vaccine strains. We found that a substantial proportion of vaccine strains had high percentages of nucleotide substitutions (>0.5%), including a type 3 VDPV with 1.4% nucleotide divergence. These findings indicate that VDPV or pre-VDPV strains are not rare in certain populations with high levels of vaccine coverage. The multiple RFLP method appears to be a simple and rapid tool for monitoring such strains, which could jeopardize the benefits of the eradication program.


* Corresponding author. Mailing address: Unité de Prévention et Thérapie Moléculaires des Maladies Humaines, Institut Pasteur, 75 724 Paris Cedex 15, France. Phone: 33 1 40 61 33 22. Fax: 33 1 45 68 87 80. E-mail for Francis Delpeyroux: delpeyro{at}pasteur.fr. E-mail for Natalia I. Romanenkova: poliospb{at}pasteur.org.ru.

{triangledown} Published ahead of print on 6 September 2006.


Journal of Clinical Microbiology, November 2006, p. 4077-4084, Vol. 44, No. 11
0095-1137/06/$08.00+0     doi:10.1128/JCM.00017-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Yakovenko, M. L., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Samoilovich, E., Uhova, I., Gavrilin, G. V., Agol, V. I. (2009). Evolution of the Sabin Vaccine into Pathogenic Derivatives without Appreciable Changes in Antigenic Properties: Need for Improvement of Current Poliovirus Surveillance. J. Virol. 83: 3402-3406 [Abstract] [Full Text]  
  • Mueller, J. E., Bessaud, M., Huang, Q. S., Martinez, L. C., Barril, P. A., Morel, V., Balanant, J., Bocacao, J., Hewitt, J., Gessner, B. D., Delpeyroux, F., Nates, S. V. (2009). Environmental Poliovirus Surveillance during Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Use in Cordoba Province, Argentina. Appl. Environ. Microbiol. 75: 1395-1401 [Abstract] [Full Text]